BVXV

BiondVax Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.06 2.0% 3.06 09:31:15
Open Price Low Price High Price Close Price Prev Close
3.05 3.05 3.06 3.00
more quote information »

Recent News

Date Time Source Heading
3/23/202107:54EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/23/202107:44PRNUSLetter from BiondVax's New CEO to Shareholders
3/22/202115:44EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/16/202111:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/04/202113:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/24/202116:58EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/17/202116:43EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/11/202106:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/10/202116:30PRNUSBiondVax Announces Exercise in Full of Underwriter's..
2/09/202106:07EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
2/08/202114:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/02/202116:37EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/02/202116:30PRNUSBiondVax Announces Closing of $12.1 Million Follow-on..
2/02/202106:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/29/202108:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/29/202107:57PRNUSBiondVax Announces Pricing of $12.1 Million Follow-on..
1/29/202106:13EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/28/202118:48PRNUSBiondVax Announces Launch of Proposed Underwritten Follow-on..
1/28/202115:23PRNUSBiondVax Announces Third Quarter 2020 Financial Results &..
1/21/202111:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/21/202107:15PRNUSBiondVax Announces Appointment of Amir Reichman as New CEO
10/23/202012:28PRNUS/C O R R E C T I O N -- BiondVax Pharmaceuticals Ltd./
10/23/202011:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/23/202010:38PRNUSBiondVax Announces Topline Results from Phase 3 Clinical..
10/02/202006:05EDGARReport of Foreign Issuer (6-k)
10/02/202006:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/02/202006:02EDGARReport of Foreign Issuer (6-k)
10/02/202006:00PRNUSBiondVax Announces At-The-Market (ATM) Equity Offering..
9/02/202013:03EDGARReport of Foreign Issuer (6-k)
9/01/202007:19EDGARReport of Foreign Issuer (6-k)
8/24/202006:10EDGARReport of Foreign Issuer (6-k)
8/20/202016:01PRNUSBiondVax Announces Second Quarter 2020 Financial Results
8/17/202006:22EDGARReport of Foreign Issuer (6-k)
8/13/202016:01PRNUSBiondVax Announces Notice of Annual General Meeting of..
8/11/202006:05EDGARNotice of Effectiveness (effect)
8/05/202013:35EDGARReport of Foreign Issuer (6-k)
7/28/202014:24EDGARReport of Foreign Issuer (6-k)
7/01/202008:20EDGARReport of Foreign Issuer (6-k)
7/01/202006:32EDGARReport of Foreign Issuer (6-k)
7/01/202006:00PRNUSLast of 12,400 Participants Completes Final Visit in..
6/30/202016:01PRNUSBiondVax Announces First Quarter 2020 Financial Results
6/22/202013:37EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/12/202008:11EDGARReport of Foreign Issuer (6-k)
6/12/202008:04EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
6/12/202008:00PRNUSBiondVax Announces Fourth Quarter and Full Year 2019..
6/10/202007:48EDGARReport of Foreign Issuer (6-k)
6/10/202007:00PRNUSNIH Report on Phase 2 Clinical Trial of BiondVax's M-001..
5/20/202007:44EDGARReport of Foreign Issuer (6-k)
5/20/202006:30PRNUSBiondVax Announces Receipt of $4.2 Million Through Exercise..
5/13/202016:34EDGARNotification Filed by National Security Exchange to Report..
See more news about this stock »
Your Recent History
NASDAQ
BVXV
BiondVax P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210422 13:47:23